RhumbLine Advisers’s Neos Therapeutics, Inc NEOS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q2 | – | Sell |
-53,730
| Closed | -$140K | – | 3036 |
|
|
2019
Q1 | $140K | Buy |
53,730
+16,288
| +44% | +$42.4K | ﹤0.01% | 2815 |
|
|
2018
Q4 | $62K | Buy |
37,442
+12,871
| +52% | +$21.3K | ﹤0.01% | 2927 |
|
|
2018
Q3 | $119K | Sell |
24,571
-1,500
| -6% | -$7.27K | ﹤0.01% | 2843 |
|
|
2018
Q2 | $163K | Buy |
26,071
+5,226
| +25% | +$32.7K | ﹤0.01% | 2786 |
|
|
2018
Q1 | $173K | Buy |
20,845
+2,685
| +15% | +$22.3K | ﹤0.01% | 2641 |
|
|
2017
Q4 | $185K | Sell |
18,160
-2,749
| -13% | -$28K | ﹤0.01% | 2654 |
|
|
2017
Q3 | $191K | Buy |
20,909
+500
| +2% | +$4.57K | ﹤0.01% | 2755 |
|
|
2017
Q2 | $149K | Buy |
20,409
+2,441
| +14% | +$17.8K | ﹤0.01% | 2840 |
|
|
2017
Q1 | $129K | Buy |
17,968
+4,985
| +38% | +$35.8K | ﹤0.01% | 2749 |
|
|
2016
Q4 | $76K | Buy |
12,983
+2,878
| +28% | +$16.8K | ﹤0.01% | 2809 |
|
|
2016
Q3 | $66K | Buy |
+10,105
| New | +$66K | ﹤0.01% | 2844 |
|